The Cancer

Don't Miss

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

Vital Information

Facts

Latest Articles

FDA Completes Finish-of-Section 2 Assembly for Annamycin Plus Cytarabine in AML

Moleculin Biotech has accomplished an end-of-phase 2 assembly with the FDA concerning the investigation of annamycin (MB-106) together with cytarabine for the remedy...

Meghan McCain compares Biden’s ‘cognitive decline’ to her father’s terminal mind most cancers battle

Meghan McCain, daughter of late Arizona Senator John McCain, has in contrast watching Joe Biden’s debate efficiency to her father’s “cognitive decline” throughout...

British Columbian most cancers affected person on receiving most cancers remedy in Washington

2 hours in the pastInformationPeriod 9:23For the previous yr the province has been sending most cancers sufferers to Bellingham, Washington for remedy as...

Developments in oncology during the last 12 months displaying promise for most cancers sufferers and others | Information

Developments in oncology during the last 12 months displaying promise for most cancers sufferers and others | Information | wevv.com ...

Some Girls in Their 40s Want to Delay Breast Most cancers Screening

MONDAY, July 15, 2024 (HealthDay Information) -- A substantial proportion of ladies aged 39 to 49 years desire to delay breast most cancers...

Hot Topics